Discovery and Structure-activity Relationships of a Series of Pyroglutamic Acid Amide Antagonists of the P2X7 Receptor
Overview
Authors
Affiliations
A computational lead-hopping exercise identified compound 4 as a structurally distinct P2X(7) receptor antagonist. Structure-activity relationships (SAR) of a series of pyroglutamic acid amide analogues of 4 were investigated and compound 31 was identified as a potent P2X(7) antagonist with excellent in vivo activity in animal models of pain, and a profile suitable for progression to clinical studies.
Liu X, Li Y, Huang L, Kuang Y, Wu X, Ma X Front Pharmacol. 2024; 15:1450704.
PMID: 39139642 PMC: 11319138. DOI: 10.3389/fphar.2024.1450704.
Involvement of microglial P2X7 receptor in pain modulation.
Zhang J, Gao L, Zhang Y, Wang H, Sun S, Wu L CNS Neurosci Ther. 2023; 30(1):e14496.
PMID: 37950524 PMC: 10805404. DOI: 10.1111/cns.14496.
Spotlight on P2X7 Receptor PET Imaging: A Bright Target or a Failing Star?.
Schmidt S, Isaak A, Junker A Int J Mol Sci. 2023; 24(2).
PMID: 36674884 PMC: 9861945. DOI: 10.3390/ijms24021374.
Territo P, Zarrinmayeh H Front Cell Neurosci. 2021; 15:617036.
PMID: 33889073 PMC: 8055960. DOI: 10.3389/fncel.2021.617036.
Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer.
Drill M, Jones N, Hunn M, OBrien T, Monif M Purinergic Signal. 2021; 17(2):215-227.
PMID: 33728582 PMC: 8155177. DOI: 10.1007/s11302-021-09776-9.